MedTrace Logo

Enhancing Conservative Treatment for Urge Incontinence

NCT00223821 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2013-12-19

Study results available
· View outcomes & findings →

Summary

The primary objective of this project is to evaluate whether enhancing drug therapy with components of behavioral training, including pelvic floor muscle rehabilitation, results in better outcomes than drug therapy alone for urge incontinence in community-dwelling women.

Conditions

Interventions

DRUG

Oxybutynin chloride, extended-release, individually-titrated

Individually-titrated, extended-release oxybutynin chloride with management of side-effects.

BEHAVIORAL

Behavior Training

Behavioral training consists of teaching urge suppression strategies and pelvic floor muscle training.

Sponsors & Collaborators

Principal Investigators

  • Kathryn L. Burgio, PhD MA BA · Birmingham, Alabama VA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2008-11-30
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00223821 on ClinicalTrials.gov